CTLA4 and neoplasm: Clinical studies using patient samples have correlated CTLA-4 expression of tumor-infiltrating T cells to ipilimumab response in melanoma using whole-exome RNA sequencing, and in NSCLC patients through IHC staining of tumor sections 132,133.